The effects of cimetidine chronic treatment on conventional antiepileptic drugs in mice

Pharmacol Rep. 2016 Apr;68(2):283-8. doi: 10.1016/j.pharep.2015.09.009. Epub 2015 Oct 9.

Abstract

Purpose: The aim of this study was to evaluate the effects of 1-day, 7-day and 14-day administrations of cimetidine on the anticonvulsant activity of conventional antiepileptic drugs (AEDs; valproate, carbamazepine, phenytoin and phenobarbital) against maximal electroshock (MES)-induced convulsions in mice.

Methods: Electroconvulsions were evoked in Albino Swiss mice by a current delivered via ear-clip electrodes. In addition, the effects of cimetidine, AEDs alone and their combinations were studied on performance and long-term memory tests. Pharmacokinetic changes in plasma and brain concentrations of AEDs after cimetidine administration were evaluated with immunofluorescence.

Results: Cimetidine (up to 100mg/kg) after 1-day administration did not affect the electroconvulsive threshold in animals. Moreover, in the 14-day treatment, cimetidine administered at a dose of 40mg/kg did not significantly change the electroconvulsive threshold in the MES-test, cimetidine administered 14-day (at 20mg/kg) significantly increased the anticonvulsant activity of carbamazepine, staying without effects after a 1-day and 7-day studies. In contrast, both the 7-day and 14-day administrations of cimetidine resulted in significant reductions of protective efficacy of the phenobarbital. Only valproate and phenytoin were not affected by cimetidine (20mg/kg) in all experimental period. Cimetidine administered 1-day, did not alter total brain concentrations and free plasma levels of all AEDs tested, whilst the 14-day study elevated carbamazepine plasma and brain concentration and reduced phenobarbital brain concentration. Cimetidine co-applied with AEDs did not impair performance of mice evaluated in the chimney test however, it worsened long-term memory in animals.

Conclusions: Based on this preclinical study, a special caution is advised when treating epileptic patients with combinations of phenobarbital or carbamazepine with cimetidine.

Keywords: Antiepileptic drugs; Cimetidine; Drug interactions; Electroshock maximal; Seizures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticonvulsants / blood
  • Anticonvulsants / metabolism
  • Anticonvulsants / pharmacology*
  • Brain / drug effects
  • Brain / metabolism
  • Carbamazepine / blood
  • Carbamazepine / metabolism
  • Carbamazepine / pharmacology
  • Cimetidine / pharmacology*
  • Drug Interactions*
  • Electroshock / methods
  • Male
  • Memory, Long-Term / drug effects
  • Mice
  • Phenobarbital / blood
  • Phenobarbital / metabolism
  • Phenobarbital / pharmacology
  • Phenytoin / blood
  • Phenytoin / metabolism
  • Phenytoin / pharmacology
  • Seizures / drug therapy*
  • Seizures / metabolism
  • Valproic Acid / blood
  • Valproic Acid / metabolism
  • Valproic Acid / pharmacology

Substances

  • Anticonvulsants
  • Carbamazepine
  • Valproic Acid
  • Phenytoin
  • Cimetidine
  • Phenobarbital